© 1996 American Heart Association, Inc.
Articles |
Characterization of the Endothelium-Specific Murine Vascular Endothelial Growth Factor Receptor-2 (Flk-1) Promoter
the Max-Planck-Institut fur Physiologische und Klinische Forschung, Bad Nauheim, Germany.
Correspondence to Dr Georg Breier, Max-Planck-Institut fur Physiologische und Klinische Forschung, Parkstr. 1, 61231 Bad Nauheim, Germany. E-mail gbreier@alpha.kerckhoff.mpg.de.
Flk-1, a high-affinity signaling receptor for vascular endothelial growth factor (VEGF), is strongly and specifically expressed on endothelial cells during embryonic development of the vascular system and during tumor angiogenesis. Disruption of Flk-1 gene function has recently been shown to prevent completely endothelial cell differentiation during murine embryonic development. To gain insights into the mechanisms that regulate the endothelium-specific Flk-1 expression, we have isolated the 5'-flanking region of the murine Flk-1 gene. RNase protection and primer extension analyses revealed a single transcriptional start site located 299 bp upstream from the translational start site in an initiator-like pyrimidine-rich sequence. The 5'-flanking region is rich in GC residues and lacks a typical TATA or CAAT box. A luciferase reporter construct containing a fragment from nucleotides -1900 to +299 showed strong endothelium-specific activity in transfected bovine aortic endothelial cells. Deletion analyses revealed that endothelium-specific Flk-1 expression is stimulated by the 5'-untranslated region of the first exon, which contains an activating element between nucleotides +137 and +299. In addition, two endothelium-specific negative regulatory elements were identified between nucleotides -4100 and -623. Two strong general activating elements were present in the region between nucleotides -96 and -37, which contains one potential NF
B and three potential AP-2 binding sites. This study shows that Flk-1 expression in endothelial cells is mainly regulated by an endothelium-specific activating element in the long 5'-untranslated region of the first exon and by negative regulatory elements located further upstream.
Key Words: endothelium • Flk-1 • mouse • promoter • vascular endothelial growth factor receptor
This article has been cited by other articles:
 |
|
 |
|
  Q. Hao, L. Wang, Z. J. Zhao, and H. Tang Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis J. Biol. Chem., January 9, 2009; 284(2): 799 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rask-Madsen and G. L. King Differential Regulation of VEGF Signaling by PKC-{alpha} and PKC-{epsilon} in Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 919 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Licht, F. Muller-Holtkamp, I. Flamme, and G. Breier Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development Blood, January 15, 2006; 107(2): 584 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hirai, I. M Samokhvalov, T. Fujimoto, S. Nishikawa, J. Imanishi, and S.-I. Nishikawa Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells Blood, September 15, 2005; 106(6): 1948 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eguchi, M. Eguchi-Ishimae, A. Green, T. Enver, and M. Greaves Directing oncogenic fusion genes into stem cells via an SCL enhancer PNAS, January 25, 2005; 102(4): 1133 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dai, R. E. McAninch, and R. E. Sutton Identification of Synthetic Endothelial Cell-Specific Promoters by Use of a High-Throughput Screen J. Virol., June 15, 2004; 78(12): 6209 - 6221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seki, K.-H. Hong, J. Yun, S.-J. Kim, and S. P. Oh Isolation of a Regulatory Region of Activin Receptor-Like Kinase 1 Gene Sufficient for Arterial Endothelium-Specific Expression Circ. Res., April 30, 2004; 94(8): e72 - e77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, Z. Fang, P. R. Contag, A. F. Purchio, and D. B. West Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood, January 15, 2004; 103(2): 617 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Elvert, A. Kappel, R. Heidenreich, U. Englmeier, S. Lanz, T. Acker, M. Rauter, K. Plate, M. Sieweke, G. Breier, et al. Cooperative Interaction of Hypoxia-inducible Factor-2alpha (HIF-2alpha ) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1) J. Biol. Chem., February 21, 2003; 278(9): 7520 - 7530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minami, D. J. Donovan, J. C. Tsai, R. D. Rosenberg, and W. C. Aird Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice Blood, December 1, 2002; 100(12): 4019 - 4025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Peng and N. Jahroudi The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter Blood, April 1, 2002; 99(7): 2408 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kappel, T. M. Schlaeger, I. Flamme, S. H. Orkin, W. Risau, and G. Breier Role of SCL/Tal-1, GATA, and Ets transcription factor binding sites for the regulation of Flk-1 expression during murine vascular development Blood, November 1, 2000; 96(9): 3078 - 3085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Illi, P. Puri, L. Morgante, M. C. Capogrossi, and C. Gaetano Nuclear Factor-{kappa}B and cAMP Response Element Binding Protein Mediate Opposite Transcriptional Effects on the Flk-1/KDR Gene Promoter Circ. Res., June 23, 2000; 86 (12): e110 - e117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kappel, V. Ronicke, A. Damert, I. Flamme, W. Risau, and G. Breier Identification of Vascular Endothelial Growth Factor (VEGF) Receptor-2 (Flk-1) Promoter/Enhancer Sequences Sufficient for Angioblast and Endothelial Cell-Specific Transcription in Transgenic Mice Blood, June 15, 1999; 93(12): 4284 - 4292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Cowan, D. Tsang, C. M. Pedic, L. R. Abbott, T. A. Shinkel, A. J.F. d'Apice, and M. J. Pearse The Human ICAM-2 Promoter is Endothelial Cell-specific in Vitro and in Vivo and Contains Critical Sp1 and GATA Binding Sites J. Biol. Chem., May 8, 1998; 273(19): 11737 - 11744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Doevendans, P. Ruiz-Lozano, and M. van Bilsen Hunting down nucleic acid binding factors in the cardiovascular system Cardiovasc Res, May 1, 1998; 38(2): 301 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Schlaeger, S. Bartunkova, J. A. Lawitts, G. Teichmann, W. Risau, U. Deutsch, and T. N. Sato Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice PNAS, April 1, 1997; 94(7): 3058 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minami, R. D. Rosenberg, and W. C. Aird Transforming Growth Factor-beta 1-mediated Inhibition of the flk-1/KDR Gene Is Mediated by a 5'-Untranslated Region Palindromic GATA Site J. Biol. Chem., February 9, 2001; 276(7): 5395 - 5402. [Abstract] [Full Text] [PDF]
|
|